Table 3.

Number and Percent of Patients With Migraine-Associated Symptoms at Baseline and 2 Hours Postdose

PlaceboSumatriptan NS (mg/Dose)
Baseline2 Hours
Postdose
Baseline51020
2 Hours
Postdose
Baseline2 Hours
Postdose
Baseline2 Hours
Postdose
Nausea, %3925462049175121
Vomiting, %55374585
Photophobia, %9048873883438436*
Phonophobia, %83448228* 75337725*
  • * P < .05 versus placebo.